Nasus Pharma Ltd (NSRX) › Operating IncomeNasus Pharma Ltd (NSRX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2023: -$1.15M2024: -$1.08M2025: -$4.90M-$4.90M2023Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$4.90M-354.9%2024-$1.08M+6.0%2023-$1.15M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share